Skip to main content
. 2020 Oct 31;12(11):1045. doi: 10.3390/pharmaceutics12111045

Table 7.

Prediction results for experimentally verified ACPs targeting mitochondria of cancer cells.

Peptide ACP AMP Negative Decision
A9K 0.10 0.32 0.58 Negative
GW-H1 0.31 0.64 0.06 AMP
hCAP-18 0.96 0.04 0.00 ACP
HPRP-A1-TAT 0.66 0.33 0.01 ACP
KLA 1.00 0.00 0.00 ACP
Lactoferricin B 0.10 0.90 0.00 AMP
Magainin 1 0.63 0.32 0.05 ACP
Mastoparan-C 0.96 0.04 0.00 ACP
NGR Peptide 1 0.65 0.35 0.00 ACP
Pleurocidin 03 0.00 1.00 0.00 AMP
R7-kla 0.96 0.04 0.00 ACP
RGD-4C-GG-(KLAKLAK)2 0.98 0.02 0.00 ACP